Poongjeon Pharmacy to Raise KRW 3 Billion in Private Share Placement
Bitget2026/10/26 07:31- Poongjeon Pharmacy announced a KRW 3 billion private placement on Oct. 26, 2026, to fund operations.
- The sale comprises 1,200,000 new common shares at KRW 2,500 each.
- Adela New Technology Fund No. 66 will receive 800,000 shares; Nova New Technology Fund No. 243 will receive 400,000 shares.
- Payment is due Nov. 10, 2026, with listing scheduled for Nov. 26, 2026.
- All new shares will be subject to a one-year lockup, exempting the offering from securities registration.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver
Driven by booming semiconductor exports, South Korea's current account surplus in September surged to a record high.
CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading
CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.
AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response
According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.
Goldman Sachs and Apollo in Talks to Sell 40 Billion-Dollar AI Chip Financing for SpaceX (SPCX.US), Market's Willingness to Take Over Faces Test
Goldman Sachs (GS.US) and Apollo Global Management (APO.US) are in talks with Wall Street investors to begin selling portions of a roughly $40 billion chip financing deal for SpaceX (SPCX.US).
Crypto prices
More
